Daniel Newman Mendelson insider trades: Champions Oncology (CSBR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | CSBR | ↑ Buy | 1,000 | $6.50 | $7K | Direct | Jan 16, 2024 (4d) |
| Jan 11, 2024 | CSBR | ↑ Buy | 2,000 | $6.27 | $13K | Direct | Jan 12, 2024 (1d) |
| Jan 10, 2024 | CSBR | ↑ Buy | 2,944 | $6.31 | $19K | Direct | Jan 11, 2024 (1d) |
| Jan 9, 2024 | CSBR | ↑ Buy | 3,000 | $6.25 | $19K | Direct | Jan 10, 2024 (1d) |
| Jan 8, 2024 | CSBR | ↑ Buy | 1,000 | $6.15 | $6K | Direct | Jan 9, 2024 (1d) |
| Jan 5, 2024 | CSBR | ↑ Buy | 2,000 | $6.09 | $12K | Direct | Jan 8, 2024 (3d) |
| Jan 4, 2024 | CSBR | ↑ Buy | 3,000 | $6.12 | $18K | Direct | Jan 8, 2024 (4d) |
| Jan 3, 2024 | CSBR | ↑ Buy | 500 | $5.83 | $3K | Direct | Jan 4, 2024 (1d) |
| Dec 21, 2023 | CSBR | ↑ Buy | 2,500 | $4.92 | $12K | Direct | Dec 26, 2023 (5d) |
| Dec 20, 2023 | CSBR | ↑ Buy | 2,100 | $4.82 | $10K | Direct | Dec 21, 2023 (1d) |
| Dec 19, 2023 | CSBR | ↑ Buy | 5,000 | $4.75 | $24K | Direct | Dec 20, 2023 (1d) |
| Oct 11, 2023 | CSBR | ↑ Buy | 5,000 | $6.40 | $32K | Direct | Oct 13, 2023 (2d) |
| Oct 10, 2023 | CSBR | ↑ Buy | 1,100 | $6.41 | $7K | Direct | Oct 11, 2023 (1d) |
| Oct 6, 2023 | CSBR | ↑ Buy | 1,530 | $6.48 | $10K | Direct | Oct 10, 2023 (4d) |
| Oct 5, 2023 | CSBR | ↑ Buy | 2,000 | $6.47 | $13K | Direct | Oct 6, 2023 (1d) |
| Oct 4, 2023 | CSBR | ↑ Buy | 5,000 | $6.40 | $32K | Direct | Oct 4, 2023 (0d) |
| Oct 3, 2023 | CSBR | ↑ Buy | 2,500 | $6.30 | $16K | Direct | Oct 4, 2023 (1d) |
| Sep 29, 2023 | CSBR | ↑ Buy | 4,000 | $6.16 | $25K | Direct | Oct 16, 2023 (17d) |
| Sep 28, 2023 | CSBR | ↑ Buy | 5,000 | $6.22 | $31K | Direct | Oct 16, 2023 (18d) |
| Sep 27, 2023 | CSBR | ↑ Buy | 1,500 | $5.95 | $9K | Direct | Oct 16, 2023 (19d) |
| Sep 26, 2023 | CSBR | ↑ Buy | 5,000 | $5.65 | $28K | Direct | Sep 27, 2023 (1d) |
| Sep 22, 2023 | CSBR | ↑ Buy | 3,812 | $5.50 | $21K | Direct | Sep 25, 2023 (3d) |
| Sep 21, 2023 | CSBR | ↑ Buy | 5,000 | $5.51 | $28K | Direct | Sep 25, 2023 (4d) |
| Sep 20, 2023 | CSBR | ↑ Buy | 4,018 | $5.51 | $22K | Direct | Sep 25, 2023 (5d) |
| Sep 19, 2023 | CSBR | ↑ Buy | 5,000 | $5.28 | $26K | Direct | Sep 25, 2023 (6d) |
| Mar 26, 2020 | CSBR | ↑ Buy | 1,220 | $5.91 | $7K | Direct | Mar 30, 2020 (4d) |
| Mar 24, 2020 | CSBR | ↑ Buy | 26 | $5.50 | $143 | Direct | Mar 26, 2020 (2d) |
| Nov 6, 2018 | CSBR | ↓ Sell | 5,000 | $13.75 | $69K | Direct | Nov 8, 2018 (2d) |
| Sep 20, 2018 | CSBR | ↓ Sell | 8,333 | $13.02 | $108K | Direct | Oct 5, 2018 (15d) |
| Mar 20, 2014 | CSBR | ↑ Buy | 100,000 | $1.08 | $108K | Indirect | Mar 21, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel Newman Mendelson's insider trades
Daniel Newman Mendelson is a director at Champions Oncology (CSBR). Since Mar 20, 2014, Daniel has reported 28 open-market purchases worth $557K and 2 sales worth $177K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (29 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CSBR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.